Close Menu

NEW YORK (360Dx) – April may not have been the cruelest month, but it wasn't benevolent either for the stocks of diagnostics firms.

A positive start to 2019 turned sour last month as most diagnostics firms' stock values declined last month compared to March, and the 360Dx Index slid slightly in April. It marked the first time this year that the index retreated month-over-month.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.